Sulfur - Generic Drug Details

What are the generic sources for sulfur and what is the scope of freedom to operate?

Sulfur is the generic ingredient in two branded drugs marketed by Poythress and Bracco, and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for sulfur.

Summary for sulfur

US Patents:	3
Tradenames:	2
Applicants:	2
NDAs:	2
Drug Master File Entries:	2
Raw Ingredient (Bulk) Api Vendors:	37
Clinical Trials:	77
Patent Applications:	33
DailyMed Link:	sulfur at DailyMed

Recent Clinical Trials for sulfur

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Societa Italiana di Chirurgia ColoRettale	N/A
Neopharmed Gentili S.p.A.	N/A
OnLume Inc.	Early Phase 1

See all sulfur clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for sulfur

D10AB	Preparations containing sulfur
D10A	ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10	ANTI-ACNE PREPARATIONS
D	Dermatologicals

US Patents and Regulatory Information for sulfur

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bracco	LUMASON	sulfur hexafluoride lipid-type a microspheres	FOR SUSPENSION;INTRAVENOUS	203684-001	Oct 15, 2014		RX	Yes	Yes			Y
Bracco	LUMASON	sulfur hexafluoride lipid-type a microspheres	FOR SUSPENSION;INTRAVENOUS	203684-001	Oct 15, 2014		RX	Yes	Yes			Y
Poythress	BENSULFOID	sulfur	POWDER;TOPICAL	002918-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Bracco	LUMASON	sulfur hexafluoride lipid-type a microspheres	FOR SUSPENSION;INTRAVENOUS	203684-001	Oct 15, 2014		RX	Yes	Yes			Y